CRISPRMED24
CRISPRMED24
  • Meet the European CRISPR Medicine/Genomic Medicine community in Copenhagen, Denmark 2024.
  • Focus: Tools, Delivery, Safety/Off-target, Diseases, Pre-clinical/clinical, Standards and Regulations | Functional Genomics, Target Identification, Target Validation.
  • Segments: University, Hospital, Biotech, Pharma, CRO.
  • +500 delegates, +25 speakers (additional +25 speakers selected from abstracts), Poster sessions, Workshops, Network meetings...
  • Early bird registration until 1st December 2023.
  • Abstract submission deadline 5th January 2024.
  • Venue Site: Øksnehallen, Copenhagen, Denmark.
  • Organiser: CRISPR Medicine News, CMN.
  • Go to the official website here.
Scientific Committee
  • Karen O´Hanlon Cohrt, Chief Editor CRISPR Medicine News, CMN
  • Toni Cathomen, Prof., Director of the Institute for Transfusion Medicine and Gene Therapy, University of Freiburg, Germany
  • Marcello Maresca, Senior Director, Genome Engineering Team, AstraZeneca, Sweden
  • Alessia Cavazza, Ass. Prof., Group Leader, University College London's Great Ormond Street Institute of Child Health, England
  • Anna Cereseto, Prof., Vice-Director, Centre for Integrative Biology (CIBIO), University of Trento, Italy
CRISPRMED24 Speakers (early confirmation)
  • Dr. André Cohnen, Head of Genomic Medicine, Senior Bayer Science Fellow, Bayer, Germany
  • Karina Thorn, Corporate Vice President, PhD, RNA and Gene Therapies, Global Research Technologies, Novo Nordisk, Denmark
  • Rasmus O. Bak, Ass. Prof. and Group leader, Aarhus University, Denmark
  • Xavier Duportet, CEO and Co-founder, Eligo Bioscience, France
  • Toni Cathomen, Prof. and Director of the Institute for Transfusion Medicine and Gene Therapy, University of Freiburg, Germany
  • Marcello Maresca, Senior Director, Genome Engineering Team, AstraZeneca, Sweden
  • Dr. Christian Groendahl, CEO and Co-founder, SNIPR Biome, Denmark
  • Dr. Pia Johansson, Manager Cell and Gene Therapy Core, Lund University, Sweden
  • Avencia Sanchez-Mejias Garcia, CEO and Co-founder, INTEGRA Therapeutics, Spain
  • Andre Choulika, CEO, Cellectis, France
  • Jan Gorodkin, Prof. and Group leader, University of Copenhagen, Denmark
  • Dr. Ayal Hendal, Principal Investigator and Group leader, Bar-Ilan University, Israel
  • Sekar Kathiresan, CEO and Founder, Verve Therapeutics, US
  • Alessia Cavazza, Ass. Prof., Group Leader, Infection, Immunity & Inflammation Department at University College London's Great Ormond Street Institute of Child Health, England
  • Yonglun Luo, Professor, Gene and Stem Cell Technology, Aarhus University, Denmark
  • Kevin Holden, PhD, Head of Science, Synthego, US
  • Dr. Manuel Kaulich, Prof., Goethe University Frankfurt, Germany
  • Anna Cereseto, Prof., Vice-Director, Centre for Integrative Biology (CIBIO), University of Trento, Italy
  • Bernhard Schmierer, Head of Unit, CRISPR Functional Genomics, SciLifeLab and Karolinska Institutet, Stockholm, Sweden
  • Dr. Ben P. Kleinstiver, PhD, Assistant Professor at Center for Genomic Medicine, Massachusetts General Hospital and Harvard Medical School, US
  • Samantha Maragh, PhD, Leader, Genome Editing Program, National Institute of Standards & Technology (NIST), US

  • ...
CRISPRMED24
CRISPRMED24
CRISPRMED24
CRISPRMED24
CRISPRMED24
CRISPRMED24
CRISPRMED24
CRISPRMED24
CRISPRMED24
CRISPRMED24
CRISPRMED24
CRISPRMED24
CRISPRMED24
CRISPRMED24
CRISPRMED24
CRISPRMED24
CRISPRMED24
CRISPRMED24
Stay Updated

Official website will be live September 2023.

Stay updated about the program, abstract submissions and early registration options - sign up to the CRISPRMED24 Newsletter.

Sorry - something went wrong, your inquiry has not been sent!!
Thanks for your interest for the CRISPR Medicine Conference 2024. We will soon share more details.

Terms and Conditions
The CRISPRMED24 Newsletter is published by CRISPR Medicine Media Aps organiser of the CRISPR Medicine Conference. The CRISPR Medicine Media team is committed to protecting and respecting my privacy. CRISPR Medicine Media will guard my information responsibly and never share my email address. When I subscribe to the CRISPRMED24 Newsletter via this online form or email, I consent to CRISPR Medicine Media registering my email address to deliver email content.I may revoke my consent at any given time. CRISPR Medicine Media will delete my contact details when I terminate my subscription.

Interested to learn more about the Sponsorship or Exhibitor Packages?

Few sponsorship packages and exhibitor spaces will be available. Contact us today to learn more.

Sorry - something went wrong, your inquiry has not been sent!!
Thanks for your interest for the CRISPR Medicine Conference 2024. We will soon share more details.
Supporters
Supporters
Supporters
Supporters
Supporters
Supporters
Supporters
Supporters
Supporters
Supporters
close
Search CRISPR Medicine